InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,884.74
(
-0.01%
)
Post# of 52323
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

mick

Send PM Follow Ignore
Followers 3155
Posts 961250
Boards Moderated 204
Alias Born 09/04/2000

mick

Member Level

Re: BottomBounce post# 50605

Friday, 10/10/2014 2:35:15 PM

Friday, October 10, 2014 2:35:15 PM

Post# of 52323
APT Therapeutics’ Apyrase-Based Investigational Drug Minimizes Damage from Heart Attack without Increasing Hemorrhage
Business Wire via Yahoo! Finance Oct 02 02:21pm
APT Therapeutics, Inc. is developing an investigational new drug, APT102, for heart attack and stroke patients. According to a recent study published in Science Translational Medicine, APT102 maintained optimal blood flow and reduced damage to the heart muscle by 80% in animal model studies of heart attack.



https://finance.search.yahoo.com/search;_ylt=AwrSyCT0CDhUfiAABLWTmYlQ;_ylc=X1MDMTM1MTE5NTAyNwRfcgMyBGJjawNkZGppMWx0YTNmcHVmJTI2YiUzRDQlMjZkJTNEc0lDNmxURnBZRUxvVTMyREpmVVBYWVVPZ3Zyd3ZKTkJQWElESXctLSUyNnMlM0RmNSUyNmklM0RRdWt6QkNIdE1KenN1c0lWOG9nOQRmcgN1aDNfZmluYW5jZV92ZXJ0X2dzBGdwcmlkA0hFMjA5N3RCVGtlR0hETWNNMlRNMUEEbXRlc3RpZANudWxsBG5fcnNsdAMxMQRuX3N1Z2cDMTAEb3JpZ2luA2ZpbmFuY2Uuc2VhcmNoLnlhaG9vLmNvbQRwb3MDMARwcXN0cgMEcHFzdHJsAwRxc3RybAMzBHF1ZXJ5A2FwdAR0X3N0bXADMTQxMjk2NjAwMDMwNgR2dGVzdGlkA251bGw-?gprid=HE2097tBTkeGHDMcM2TM1A&pvid=79DcqjIwNi7WzkGvVDfnzwTJNjYuNVQ4CPT_z9Lo&p=apt&fr2=sb-top-finance.search.yahoo.com&fr=uh3_finance_vert_gs&type=2button
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up